When 115 health-care workers participated in a study that monitored th
eir serological responses to hepatitis B vaccine at regular intervals,
it was found that smoking significantly affected their antibody title
responses adversely. The study group was randomly allocated into two
comparable groups that received hepatitis B vaccine either in a rapid
schedule (vaccination at 0, 1, 2 and 12 months) or a standard schedule
- most commonly used worldwide - (vaccination at 0, 1, and 6 months).
A significantly higher proportion of smokers, in both schedules, fail
ed to seroconvert and to achieve higher antibody levels at month 3 (p
= 0.01) and at month 13 (p = 0.0003). At month 7 a similar pattern was
noted in smokers following the standard vaccination schedule (p less
than or equal to 0.05), but not in those following the rapid schedule.